LEQEMBI shows high treatment persistence in real-world study Mar 20, 2026 12:13PM
Biogen (BIIB) and Eisai: CHMP Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease Feb 28, 2025 08:24AM
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Nov 14, 2024 01:35PM